Search All News
Five-year Columbia clinical trial indicates rapid cognitive shift diminishes suicidal thoughts, independently of improvement in depressive symptoms
Dr. J. John Mann joins Dr. Lloyd Sederer on Medscape to discuss the effectiveness of Ketamine as a treatment for depression.
Excited delirium has no standard definition. The commonly cited characteristics include superhuman strength, imperviousness to pain and wild, uncontrollable behavior, said Dr. Paul S. Appelbaum.
Source:HealthlineDecember 12, 2019
Dr. Elias Dakwar said he became interested in ketamine as a potential treatment for alcohol use disorder after seeing good results from using the drug to treat cocaine addiction.
- December 5, 2019
Researchers findings at Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute could lead to a new approach to the treatment of alcohol use disorder.
Source:Philly VoiceDecember 5, 2019
"In our participants, ketamine appears to have increased resilience and reduced demoralization after a lapse," Dr. Elias Dakwar said.
Source:FilterDecember 5, 2019
Dr. Elias Dakwar has conducted laboratory and clinical investigations of ketamine infusion and mindfulness training to treat cocaine use disorder.
Source:MD MagazineJune 26, 2019
Dr. Elias Dakwar sought proof of the suggestion that concentrated doses of ketamine may help reduce vulnerabilities associated with cocaine use, and improve the likelihood of relapse prevention.
Source:Brooklyn EagleApril 17, 2019
Dr. J. John Mann says while there are clear short-term benefits to ketamine, its long-term effects, its abuse potential and the optimal number of treatments a patient should receive are still unknown.
Source:MD MagazineMarch 8, 2019
Dr. Jeffrey Lieberman’s concerns about whether dosing strategies for ketamine have been properly set by clinical trials are mentioned in this Q&A.
Source:HealioFebruary 20, 2019
Dr. J. John Mann writes that ketamine “has a fairly robust effect on reducing suicidal ideation.”
- February 8, 2019
The Columbia Ketamine program offers innovative and responsible care for treatment-resistant depression.